The content is available as a PDF (84.1 KB).
. 2009 Mar 31;9:224–228. doi: 10.1100/tsw.2009.28
Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
Peter J Little
1,2,*, Neale Cohen
3, Grant Morahan
4
Peter J Little
1
Diabetes and Cell Biology Laboratory,
BakerIDI Heart and Diabetes Institute,
Melbourne, VIC 3004,
Australia
2
Medicine and Immunology Departments,
Central and Eastern Clinical School,
Alfred Hospital,
Monash University,
Melbourne, VIC 3004,
Australia
Find articles by Peter J Little
Neale Cohen
3
Clinical Services Division,
BakerIDI Heart and Diabetes Institute,
Melbourne,VIC 3004,
Australia
Find articles by Neale Cohen
Grant Morahan
4
Centre for Diabetes Research,
Western Australian Institute for Medical Research,
50 Murray Street, Perth WA 6000,
Australia
Find articles by Grant Morahan
1
Diabetes and Cell Biology Laboratory,
BakerIDI Heart and Diabetes Institute,
Melbourne, VIC 3004,
Australia
2
Medicine and Immunology Departments,
Central and Eastern Clinical School,
Alfred Hospital,
Monash University,
Melbourne, VIC 3004,
Australia
3
Clinical Services Division,
BakerIDI Heart and Diabetes Institute,
Melbourne,VIC 3004,
Australia
4
Centre for Diabetes Research,
Western Australian Institute for Medical Research,
50 Murray Street, Perth WA 6000,
Australia
✉
*Peter J. Little: peter.little@bakeridi.edu.au
Academic Editor: Lawrence A. Frohman
Received 2009 Jan 16; Revised 2009 Mar 17; Accepted 2009 Mar 19; Collection date 2009.
Keywords: Type 1 diabetes, Type 2 diabetes, imatinib, autoimmunity, NOD mouse
Copyright © 2009 Peter J. Little et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC5823116 PMID: 19347233